178 related articles for article (PubMed ID: 34814825)
1. GSA: an independent development algorithm for calling copy number and detecting homologous recombination deficiency (HRD) from target capture sequencing.
Chen D; Shao M; Meng P; Wang C; Li Q; Cai Y; Song C; Wang X; Shi T
BMC Bioinformatics; 2021 Nov; 22(1):562. PubMed ID: 34814825
[TBL] [Abstract][Full Text] [Related]
2. Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD).
Menzel M; Endris V; Schwab C; Kluck K; Neumann O; Beck S; Ball M; Schaaf C; Fröhling S; Lichtner P; Schirmacher P; Kazdal D; Stenzinger A; Budczies J
Transl Oncol; 2023 Sep; 35():101706. PubMed ID: 37327584
[TBL] [Abstract][Full Text] [Related]
3. Concordance between single-nucleotide polymorphism-based genomic instability assays and a next-generation sequencing-based homologous recombination deficiency test.
Cristescu R; Liu XQ; Arreaza G; Chen C; Albright A; Qiu P; Marton MJ
BMC Cancer; 2022 Dec; 22(1):1310. PubMed ID: 36517748
[TBL] [Abstract][Full Text] [Related]
4. Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes.
Timms KM; Abkevich V; Hughes E; Neff C; Reid J; Morris B; Kalva S; Potter J; Tran TV; Chen J; Iliev D; Sangale Z; Tikishvili E; Perry M; Zharkikh A; Gutin A; Lanchbury JS
Breast Cancer Res; 2014 Dec; 16(6):475. PubMed ID: 25475740
[TBL] [Abstract][Full Text] [Related]
5. Optical Genome Mapping: Integrating Structural Variations for Precise Homologous Recombination Deficiency Score Calculation.
Sahajpal NS; Mondal AK; Vashisht A; Singh H; Pang AWC; Saul D; Nivin O; Hilton B; DuPont BR; Kota V; Savage NM; Hastie AR; Chaubey A; Kolhe R
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761823
[TBL] [Abstract][Full Text] [Related]
6. AbsCN-seq: a statistical method to estimate tumor purity, ploidy and absolute copy numbers from next-generation sequencing data.
Bao L; Pu M; Messer K
Bioinformatics; 2014 Apr; 30(8):1056-1063. PubMed ID: 24389661
[TBL] [Abstract][Full Text] [Related]
7. Homologous recombination deficiency prediction using low-pass whole genome sequencing in breast cancer.
Liu Y; Li Y; Zhang MZ; Chen D; Leng Y; Wang J; Han BW; Wang J
Cancer Genet; 2023 Apr; 272-273():35-40. PubMed ID: 36758499
[TBL] [Abstract][Full Text] [Related]
8. Homologous Recombination Abnormalities Associated With
Albitar M; Zhang H; Pecora A; Waintraub S; Graham D; Hellmann M; McNamara D; Charifa A; De Dios I; Ma W; Goy A
Breast Cancer (Auckl); 2023; 17():11782234231198979. PubMed ID: 37789896
[TBL] [Abstract][Full Text] [Related]
9. Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in Tumor.
Ball M; Ourailidis I; Kluck K; Menzel M; Kirchner M; Allgäuer M; Tay TKY; Schnecko F; Volckmar AL; Goldschmid H; Neuman O; Fröhling S; Schirmacher P; Budczies J; Stenzinger A; Kazdal D
J Mol Diagn; 2024 Jun; 26(6):479-486. PubMed ID: 38522840
[TBL] [Abstract][Full Text] [Related]
10. Homologous Recombination Repair Mechanisms in Serous Endometrial Cancer.
Jönsson JM; Bååth M; Björnheden I; Sahin ID; Måsbäck A; Hedenfalk I
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33445465
[TBL] [Abstract][Full Text] [Related]
11. RediScore: Prospective validation of a pipeline for homologous recombination deficiency analysis.
Tsantikidi A; Papazisis K; Floros T; Gazouli M; Papadopoulou E; Tsaousis G; Nasioulas G; Mester A; Milan KP; Gozman B; Afrasanie V; Stanculeanu DL; Trifanescu O; Pescaru F; Militaru C; Papadimitriou C
Oncol Lett; 2023 Nov; 26(5):480. PubMed ID: 37809048
[TBL] [Abstract][Full Text] [Related]
12. Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort.
Leibowitz BD; Dougherty BV; Bell JSK; Kapilivsky J; Michuda J; Sedgewick AJ; Munson WA; Chandra TA; Dry JR; Beaubier N; Igartua C; Taxter T
BMC Cancer; 2022 May; 22(1):587. PubMed ID: 35643464
[TBL] [Abstract][Full Text] [Related]
13. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data.
Favero F; Joshi T; Marquard AM; Birkbak NJ; Krzystanek M; Li Q; Szallasi Z; Eklund AC
Ann Oncol; 2015 Jan; 26(1):64-70. PubMed ID: 25319062
[TBL] [Abstract][Full Text] [Related]
14. Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes.
da Costa AABA; do Canto LM; Larsen SJ; Ribeiro ARG; Stecca CE; Petersen AH; Aagaard MM; de Brot L; Baumbach J; Baiocchi G; Achatz MI; Rogatto SR
BMC Cancer; 2019 May; 19(1):422. PubMed ID: 31060523
[TBL] [Abstract][Full Text] [Related]
15. Ploidy- and Purity-Adjusted Allele-Specific DNA Analysis Using CLONETv2.
Prandi D; Demichelis F
Curr Protoc Bioinformatics; 2019 Sep; 67(1):e81. PubMed ID: 31524989
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer.
Patel JN; Braicu I; Timms KM; Solimeno C; Tshiaba P; Reid J; Lanchbury JS; Darb-Esfahani S; Ganapathi MK; Sehouli J; Ganapathi RN
Br J Cancer; 2018 Oct; 119(9):1060-1066. PubMed ID: 30318511
[TBL] [Abstract][Full Text] [Related]
17. Copy number alteration features in pan-cancer homologous recombination deficiency prediction and biology.
Yao H; Li H; Wang J; Wu T; Ning W; Diao K; Wu C; Wang G; Tao Z; Zhao X; Chen J; Sun X; Liu XS
Commun Biol; 2023 May; 6(1):527. PubMed ID: 37193789
[TBL] [Abstract][Full Text] [Related]
18. Accurity: accurate tumor purity and ploidy inference from tumor-normal WGS data by jointly modelling somatic copy number alterations and heterozygous germline single-nucleotide-variants.
Luo Z; Fan X; Su Y; Huang YS
Bioinformatics; 2018 Jun; 34(12):2004-2011. PubMed ID: 29385401
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for Homologous Recombination Deficiency in Cancer.
Hoppe MM; Sundar R; Tan DSP; Jeyasekharan AD
J Natl Cancer Inst; 2018 Jul; 110(7):704-713. PubMed ID: 29788099
[TBL] [Abstract][Full Text] [Related]
20. Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types.
Takamatsu S; Brown JB; Yamaguchi K; Hamanishi J; Yamanoi K; Takaya H; Kaneyasu T; Mori S; Mandai M; Matsumura N
JCO Precis Oncol; 2022 May; 6():e2200085. PubMed ID: 35613413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]